Steinberg v. OPKO Health, Inc.
OPKO Health Securities Litigation
Case No. 1:18-cv-23786-MARTINEZ-OTAZO-REYES (S.D. Fla.)

Welcome to the Steinberg v. Opko Health, Inc. Settlement Website

Update on the Distribution of the U.S. Net Settlement Fund
The Court has approved the distribution of the U.S. portion of the Net Settlement Fund to eligible Court-approved Claimants who qualified for an award under the Plan of Allocation. A distribution of funds has occurred on the following date/s:
May 12, 2022

Subsequent distributions will occur on a rolling basis.

If you submitted a Claim in this case and have any questions related to that Claim, please contact the Claims Administrator whose contact information is listed here below:

Please Note: The Claim Form is no longer available.

The information contained on this website is only a summary of the information presented in more detail in the Notice of (I) Pendency of Class Action and Proposed Settlement; (II) Settlement Fairness Hearing; and (III) Motion for an Award of Attorneys’ Fees and Litigation Expenses. Because this website is just a summary, you should review the Notice for additional details.

Summary of the Action and Settlement

Lead Plaintiff, on behalf of itself and the Settlement Class, has settled the Action in exchange for $16,500,000 in cash (the “Settlement”).

The Court held a hearing to consider approval of the Settlement and related matters on December 15, 2020.  On April 28 and 29, 2021, the Court entered a Final Judgment and an Order finally approving the Settlement and approving the proposed Plan of Allocation, and an Order awarding attorneys’ fees and expenses.

The Net Settlement Fund (i.e., the Settlement Amount plus any and all interest earned thereon (the “Settlement Fund”) less (i) any Taxes; (ii) any Notice and Administration Costs; (iii) any Litigation Expenses awarded by the Court; (iv) any attorneys’ fees awarded by the Court; and (v) any other costs or fees approved by the Court) will be distributed in accordance with the Plan of Allocation approved by the Court.  The Court-approved Plan of Allocation, which will determine how the Net Settlement Fund shall be allocated among members of the Settlement Class, is set forth in Appendix A at the end of the Notice.

We filed the distribution motion on November 19, 2021. The initial distribution occurred on May 12, 2022. Subsequent distributions will occur on a rolling basis.

Please read the Notice to fully to understand your rights.

If you purchased OPKO common stock only on the Tel Aviv Stock Exchange (“TASE”) you do not need to submit a Claim Form. Those Settlement Class Members will be eligible to receive a distribution from the Settlement, based on the shares they purchased on the TASE without submitting a Claim Form.

How do I obtain more information?

More detailed information about the Action and the Settlement is contained in the Notice. If you have questions, you may contact the Claims Administrator by calling toll-free 1-888-383-0345; emailing; or mailing a letter to:

OPKO Health Securities Litigation
c/o JND Legal Administration
P.O. Box 91360
Seattle, WA 98111


Inquiries should NOT be directed to the Court, the Clerk of the Court, Defendants, or their counsel.

For More Information

Visit this website often to get the most up-to-date information.


OPKO Health Securities Litigation
c/o JND Legal Administration
PO Box 91360
Seattle, WA 98111